In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

The British Horseracing Authority (BHA) has today published the following updates regarding medication control. This includes ...

The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chro ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Colorful dyes, chemical preservatives, and other once-common additives are now banned in many parts of the world as we better ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect millions of people ...

The use of beta-agonists in beef cattle production has been highly scrutinized following concerns of animal welfare, which has led to the removal of Zilmax from the market by the manufacturer.

To determine the clinical effectiveness and assess the adverse effects of regular treatment with short-acting beta-2 agonists bronchodilators in patients with stable COPD.

Patients with glaucoma using fixed combination therapy may experience faster presbyopia progression than those using monotherapy.